121 related articles for article (PubMed ID: 36542613)
1. A study protocol to explore and implement community-based point-of-care COVID-19 testing for women who use drugs in Baltimore, Maryland: The CARE study.
Tomko C; Clouse E; Haney K; Galai N; Footer K; Ferryman K; Smith KC; Sherman SG
PLoS One; 2022; 17(12):e0277605. PubMed ID: 36542613
[TBL] [Abstract][Full Text] [Related]
2. External resilience in the context of drug use and socio-structural vulnerabilities: a qualitative exploration among women who use drugs and sell sex in Baltimore, Maryland.
Tomko C; Nestadt DF; Weicker NP; Rudzinski K; Underwood C; Kaufman MR; Sherman SG
Harm Reduct J; 2022 Aug; 19(1):94. PubMed ID: 36002879
[TBL] [Abstract][Full Text] [Related]
3. The EMERALD (Enabling Mobilization, Empowerment, Risk Reduction, and Lasting Dignity) Study: Protocol for the Design, Implementation, and Evaluation of a Community-Based Combination HIV Prevention Intervention for Female Sex Workers in Baltimore, Maryland.
Silberzahn BE; Tomko CA; Clouse E; Haney K; Allen ST; Galai N; Footer KHA; Sherman SG
JMIR Res Protoc; 2021 Apr; 10(4):e23412. PubMed ID: 33861210
[TBL] [Abstract][Full Text] [Related]
4. Using the multiphase optimization strategy (MOST) framework to optimize an intervention to increase COVID-19 testing for Black and Latino/Hispanic frontline essential workers: A study protocol.
Gwadz M; Cleland CM; Lizardo M; Hawkins RL; Bangser G; Parameswaran L; Stanhope V; Robinson JA; Karim S; Hollaway T; Ramirez PG; Filippone PL; Ritchie AS; Banfield A; Silverman E
BMC Public Health; 2022 Jun; 22(1):1235. PubMed ID: 35729622
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Testing and Social Determinants of Health Among Disadvantaged Baltimore Neighborhoods: A Community Mobile Health Clinic Outreach Model.
Baker DR; Cadet K; Mani S
Popul Health Manag; 2021 Dec; 24(6):657-663. PubMed ID: 34030489
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Coalition of Faith Leaders, Community Organizations, and Governmental Organizations to Implement a COVID-19 Campaign in a Latino Neighborhood, Baltimore, Maryland, 2020-2021.
Bigelow BF; Martínez DA; Phillips K; Parent C; Saxton RE; Yang C; Page KR
Am J Public Health; 2022 Nov; 112(S9):S913-S917. PubMed ID: 36446060
[TBL] [Abstract][Full Text] [Related]
8. HIV seroconversion among Baltimore City residents tested at a mobile van programme.
Puryear S; Burnett P; Page KR; Muvva R; Chaulk P; Ghanem KG; Monroe A
Sex Transm Infect; 2018 Feb; 94(1):37-39. PubMed ID: 28899995
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 Vaccine Hesitancy and Vaccination Status in a Community-Based Cohort of People Who Inject Drugs in Baltimore, Maryland, March-June 2021.
Cepeda JA; Feder KA; Astemborski J; Schluth C; Kirk GD; Mehta SH; Genberg BL
Public Health Rep; 2022; 137(5):1031-1040. PubMed ID: 35848111
[TBL] [Abstract][Full Text] [Related]
10. The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: A rapid phone survey in Baltimore, Maryland.
Genberg BL; Astemborski J; Piggott DA; Woodson-Adu T; Kirk GD; Mehta SH
Drug Alcohol Depend; 2021 Apr; 221():108584. PubMed ID: 33607497
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
12. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
[TBL] [Abstract][Full Text] [Related]
13. Barriers and facilitators to retaining a cohort of street-based cisgender female sex workers recruited in Baltimore, Maryland, USA: results from the SAPPHIRE study.
Silberzahn BE; Morris MB; Riegger KE; White RH; Tomko CA; Park JN; Footer KHA; Huettner SS; Sherman SG
BMC Public Health; 2020 Apr; 20(1):585. PubMed ID: 32349728
[TBL] [Abstract][Full Text] [Related]
14. Behavioral economics-based incentives supported by mobile technology on HIV knowledge and testing frequency among Latino/a men who have sex with men and transgender women: Protocol for a randomized pilot study to test intervention feasibility and acceptability.
Linnemayr S; MacCarthy S; Kim A; Giguere R; Carballo-Dieguez A; Barreras JL
Trials; 2018 Oct; 19(1):540. PubMed ID: 30290851
[TBL] [Abstract][Full Text] [Related]
15. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
[TBL] [Abstract][Full Text] [Related]
16. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
[TBL] [Abstract][Full Text] [Related]
17. WYZ: a pilot study protocol for designing and developing a mobile health application for engagement in HIV care and medication adherence in youth and young adults living with HIV.
Erguera XA; Johnson MO; Neilands TB; Ruel T; Berrean B; Thomas S; Saberi P
BMJ Open; 2019 May; 9(5):e030473. PubMed ID: 31061063
[TBL] [Abstract][Full Text] [Related]
18. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.
Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H
BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978
[TBL] [Abstract][Full Text] [Related]
19. Integrated point-of-care testing (POCT) for HIV, syphilis, malaria and anaemia at antenatal facilities in western Kenya: a qualitative study exploring end-users' perspectives of appropriateness, acceptability and feasibility.
Young N; Achieng F; Desai M; Phillips-Howard P; Hill J; Aol G; Bigogo G; Laserson K; Ter Kuile F; Taegtmeyer M
BMC Health Serv Res; 2019 Jan; 19(1):74. PubMed ID: 30691447
[TBL] [Abstract][Full Text] [Related]
20. Integrating Rapid Diabetes Screening Into a Latinx Focused Community-Based Low-Barrier COVID-19 Testing Program.
Kerkhoff AD; Rojas S; Black D; Ribeiro S; Rojas S; Valencia R; Lemus J; Payan J; Schrom J; Jones D; Manganelli S; Bandi S; Chamie G; Tulier-Laiwa V; Petersen M; Havlir D; Marquez C
JAMA Netw Open; 2022 May; 5(5):e2214163. PubMed ID: 35616939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
